AnalyzeDirect

Frank JA, Stone LA, Smith ME, Albert PS, Maloni H, McFarland HF. Serial contrast-enhanced magnetic resonance imaging in patients with early relapsing-remitting multiple sclerosis: implications for treatment trials. Ann Neurol. July 1994;36 Suppl:S86-90.

Publication Date
July 1994

How Analyze was Used
“Gd-DTPA-enhanced T1-weighted images were also transferred to a Unix-based workstation and areas of Gd-DTPA enhancing were measured on each slice using Analyze 5.0.1.”

Keywords
Adult
Blood-Brain Barrier
Brain/pathology
Chronic Disease
Clinical Trials as Topic/methods/statistics & numerical data
Gadolinium DTPA
Humans
Longitudinal Studies
Magnetic Resonance Imaging (MRI)/methods/statistics & numerical data
Middle Aged
Multiple Sclerosis/classification/diagnosis/pathology
Neurologic Examination
Organometallic Compounds/diagnostic use
Pentetic Acid/analogs & derivatives/diagnostic use
Recurrence
Severity of Illness Index
Treatment Outcome

Author Affiliation(s)
Laboratory of Diagnostic Radiology Research, Office of Intramural Research, National Institutes of Health, Bethesda, MD, US. (JAF)

Neuroimmunology Branch, National Institutes of Health, Bethesda, MD, US. (LAS, MES, HM, HFM)

Biometry and Field Studies Branch, National Institute of Neurological Diseases and Stroke, National Institutes of Health, Bethesda, MD, US. (PSA)

ID# 3089

Tags: Adult, Blood-Brain Barrier, Brain/pathology, Chronic Disease, Clinical Trials as Topic/methods/statistics & numerical data, Gadolinium DTPA, Humans, Longitudinal Studies, Magnetic Resonance Imaging (MRI)/methods/statistics & numerical data, Middle Aged, Multiple Sclerosis/classification/diagnosis/pathology, Neurologic Examination, Organometallic Compounds/diagnostic use, Pentetic Acid/analogs & derivatives/diagnostic use, Recurrence, Severity of Illness Index, Treatment Outcome